20251119_INAF_Pengumuman RUPS_31986261_lamp2.pdf

                                  ANNOUNCEMENT
                   EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                                 PT INDOFARMA TBK

Hereby the Board of Directors of PT Indofarma Tbk ("Company") announce that the Extraordinary
General Meeting of Shareholders (“EGMS”) will be held on Monday, December 22, 2025.

In accordance with the Financial Services Authority Regulation No. 15/POJK.04/2020 concerning
the Plan and Implementation of General Meetings of Shareholders of Public Companies, in
conjunction with Regulation No. 16/POJK.04/2020 concerning the Implementation of Electronic
General Meetings of Shareholders of Public Companies (“OJK Regulations”), the Notice of the
EGMS will be announced through the eASY.KSEI platform accessible at https://akses.ksei.co.id,
the e-RUPS service provider’s website, the Indonesia Stock Exchange website, and the Company’s
website (www.indofarma.id) on 01 December 2025.

Shareholders entitled to attend or be represented in the EGMS are those whose names are
recorded in the Company’s Shareholders Register and/or owners of the Company’s shares in the
sub-securities accounts held at the collective custody of PT Kustodian Sentral Efek Indonesia
(“KSEI”) at the closing of trading on the Indonesia Stock Exchange on 28 November 2025.

Pursuant to the OJK Regulations and Article 23 of the Company’s Articles of Association, one (1)
or more Shareholders representing at least 1/20 (one-twentieth) of the total shares with valid
voting rights, as well as the holder of the Series A Dwiwarna Share, are entitled to propose agenda
items for the EGMS. Such proposals must be submitted in writing to the Board of Directors of the
Company no later than 7 (seven) days prior to the date of the Notice of the EGMS, i.e., 24
November 2025, accompanied by the reasons and supporting materials for the proposed agenda,
and must not contravene any prevailing laws and regulations.

                                   Jakarta, 17 November 2025
                                        PT Indofarma Tbk
                                     The Board of Directors